Physicians who use complementary and alternative therapies in their clinical practices often face charges from their respective state boards of medicines for practicing “outside the standard of care.” USA Today has conducted a review of the state pharmacy board panels, who are assigned to oversee prescription drug safety for American consumers. They found that nearly […]
Freedom of healthcare choice has long been an issue when dealing with government-funded healthcare plans like Medicare and Medicaid. For instance, the Watson-Burton legislation attempted to address economically disadvantaged persons who rely on Medicaid for health insurance because they were given no dental freedom of choice. For most families on Medicaid, the choice is either […]
An inflammatory article appeared last week in the Wall Street Journal called “The Touch that Doesn’t Heal .” It deserves a thorough reading and some impassioned letters to the editor. The article, written by Steve Salerno, claims that “Americans pay billions for alternative medicine—with nothing to show for it.”
The Promotional Products Association International is a trade group of very unhappy companies facing a severe downturn in business. These companies provide the promotional products which drug makers use to influence physician prescribing habits.
Researchers from NIH’s Women’s Health Initiative released a study this December tying the use of synthetic prescription hormones to breast cancer.
In July 2005, the FDA banned the use of an animal antibiotic called Baytril, citing a threat to human health.
Sen. Charles Grassley (R-IA), a member of the Senate Finance Committee, has repeatedly made the news with his ongoing investigation into drug industry influence on doctors.
The Wall Street Journal recently published an article entitled “What You Don’t Know About a Drug Can Hurt You.”
The FDA invited comment about how to interpret Section 912, Provision 301 of the FDA Amendments Act of 2007.